FROSTY, NCT02014649: Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza |
|
|
| Terminated | 1/2 | 15 | US | 20 mg laninamivir octanoate, CS-8958, Placebo, Lactose, 40 mg laninamivir octanoate | Biota Scientific Management Pty Ltd, Department of Health and Human Services | Influenza | 04/14 | 05/14 | | |
